Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

PURPOSE: The aim of this study was to develop a pragmatic nomogram for prediction of progressionfree survival (PFS) for the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in EGFR mutant non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: A total of 306 recurred or met...

Descripción completa

Detalles Bibliográficos
Autores principales: Keam, Bhumsuk, Kim, Dong-Wan, Park, Jin Hyun, Lee, Jeong-Ok, Kim, Tae Min, Lee, Se-Hoon, Chung, Doo Hyun, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206063/
https://www.ncbi.nlm.nih.gov/pubmed/25036571
http://dx.doi.org/10.4143/crt.2013.120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206063/
https://www.ncbi.nlm.nih.gov/pubmed/25036571
http://dx.doi.org/10.4143/crt.2013.120

Ejemplares similares